Ultimovacs has implemented cash-saving strategies, including a 40% workforce reduction, to extend its reserves into Q4 2025.

Sanofi has moved its natural killer (NK) cell engager candidate SAR443579/IPH6101 to a Phase II trial evaluating the drug’s ...

The trial will assess sovilnesib in patients with platinum-resistant or refractory high-grade serous ovarian cancer. Credit: Tattoboo / Shutterstock.com. Volastra Therapeutics has announced the dosing ...

SanaClis, a global full-service CRO with an integrated clinical supply chain, has officially acquired S2 ScienceSolutions, an owner-managed contract research organisation based in Vienna, Austria. The ...

Ultimovac’s UV1 works by inducing T cell response against telomerase reverse transcriptase (hTERT) – a protein that provides the limitless self-renewal hallmark in cancer progression. Image Credit: CI ...

Novartis’ Fabhalta was well-tolerated in the trial, with a safety profile in line with prior data. Credit: JHVEPhoto / Shutterstock. Swiss pharmaceutical company Novartis has published pre-specified ...

The device is being evaluated in the ELITE Venous clinical study. Image credit: Shutterstock/Rost9. Vivasure Medical has treated the first venous patient in a clinical trial investigating its PerQseal ...

Fragile X Syndrome typically affects males more severely compared to females and is a significant cause of inherited intellectual disability and autism. Credit: bangoland via Shutterstock. Spinogenix ...

The trial evaluated the safety, pharmacokinetics and tolerability of sevasemten in patients with Becker. Credit: 24K-Production / Shutterstock. US-based biotechnology company Edgewise Therapeutics has ...

KOLs previously interviewed by GlobalData emphasised that the success of levodopa infusion systems required the avoidance of infusion-site reactions. Credit: Kateryna Kon via Shutterstock. At the ...

Neumora’s NMRA-266 is a positive allosteric modulator (PAM) of the M4 muscarinic receptor. Credit: Monster Ztudio / Shutterstock. The US Food and Drug Administration (FDA) has placed a clinical hold ...